Does IMATINIB Cause Pericardial effusion? 223 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 223 reports of Pericardial effusion have been filed in association with IMATINIB (Imatinib). This represents 0.5% of all adverse event reports for IMATINIB.
223
Reports of Pericardial effusion with IMATINIB
0.5%
of all IMATINIB reports
18
Deaths
106
Hospitalizations
How Dangerous Is Pericardial effusion From IMATINIB?
Of the 223 reports, 18 (8.1%) resulted in death, 106 (47.5%) required hospitalization, and 23 (10.3%) were considered life-threatening.
Is Pericardial effusion Listed in the Official Label?
Yes, Pericardial effusion is listed as a known adverse reaction in the official FDA drug label for IMATINIB.
What Other Side Effects Does IMATINIB Cause?
Death (9,708)
Drug ineffective (2,628)
Nausea (2,379)
Diarrhoea (2,203)
Fatigue (1,810)
Malignant neoplasm progression (1,716)
Vomiting (1,599)
Malaise (1,361)
Drug intolerance (1,354)
Drug resistance (1,293)
What Other Drugs Cause Pericardial effusion?
TREPROSTINIL (584)
IBRUTINIB (467)
CYCLOPHOSPHAMIDE (458)
NIVOLUMAB (454)
METHOTREXATE (412)
MACITENTAN (407)
DASATINIB (388)
ADALIMUMAB (374)
AMBRISENTAN (371)
PEMBROLIZUMAB (362)
Which IMATINIB Alternatives Have Lower Pericardial effusion Risk?
IMATINIB vs IMBRUVICA
IMATINIB vs IMDEVIMAB
IMATINIB vs IMEGLIMIN
IMATINIB vs IMETELSTAT
IMATINIB vs IMIDAPRIL